Chargement en cours...
Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?
Background: Anti-Xa monitoring is utilized to measure the extent of anticoagulation in certain patient populations receiving enoxaparin. It is essential to accurately obtain this pharmacodynamic marker for safe and effective anticoagulation management. Objectives: To determine the frequency of corre...
Enregistré dans:
| Publié dans: | Hosp Pharm |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Thomas Land Publishers, Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396989/ https://ncbi.nlm.nih.gov/pubmed/28439136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5203-214 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|